Breakthrough study targets tumor cell clusters to prevent metastasis

Certain tumor types do not remain at their point of origin but spread throughout the body and form metastases.

Xenetic to advance DNase programme with UVA partnership

Share this article Under the agreement, the parties will develop Xenetic’s DNase-based platform. Credit: Maksim Shmeljov/Shutterstock.com. Xenetic Biosciences has entered into research funding and material

January 18, 2024

Risk Adjusted Net Present Value: What is the current valuation of Celltrion’s Tocilizumab biosimilar

The revenue for Tocilizumab biosimilar is expected to reach an annual total of $243 mn by 2039 globally based off GlobalData’s Revenue Model. The drug’s

September 19, 2023

Multiply Labs and GenScript partner on cell isolation automation

Share this article The automation of cell isolation is said to be a key step in improving the efficiency and scalability of cell therapies. Credit:

April 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.